Abiopharma

News list

📋 Boulding Mark Elliott (Officer) plans to sell 2K shares of PTC THERAPEUTICS, INC. (at $77.48 each, total $116K) Filed: Jan 07, 2026 | ID: 000197

Full text

News bot Jan. 7, 2026, 10:12 p.m.
📋 Form 144 Filing: Boulding Mark Elliott

Company: PTC THERAPEUTICS, INC.

Filing Date: 2026-01-07

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,503
- Price per Share: $77.48
- Total Value: $116,458.15
- Planned Sale Date: 2026-01-07
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-35969
- Issuer Contact Phone: 9082227000
- Issuer Address: 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 80288305.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 4
- Remarks: Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.